Developer docs
API playgroundTry for free, no card

Search company profiles

Breast Cancer Canada

Full company profile

uuid0009ecc

Namestring
Breast Cancer Canada
Legal namestring
Breast Cancer Canada
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Breast Cancer Canada is a national nonprofit organization founded in 1991 and headquartered in Sarnia, Canada, dedicated to advancing breast cancer research, survivorship support, and patient advocacy across Canada. The organization serves three primary constituencies: breast cancer patients and survivors (the primary segment, focused on post-treatment physical, emotional, and financial support), provincial healthcare systems and governments (addressing diagnostic capacity and wait-list disparities), and healthcare providers and clinicians (advancing standardized, evidence-based treatment standards). Its core programs include the National Survivorship Strategy (launched in 2026 as its fifth strategic pillar with a $200,000 AstraZeneca Canada partnership), the National Consensus Recommendations for Breast Cancer Care co-developed with the REAL Canadian Breast Cancer Alliance and published in Current Oncology, an annual Progress Report tracking the state of breast cancer care in Canada, the Walk-a-Thon to Mother's Day national fundraising event, and the Lobular Breast Cancer Awareness Initiative conducted with the Lobular Breast Cancer Alliance.

The organization's underlying 'product' surface is programmatic rather than technological: clinical guidelines, research reports, awareness campaigns, and survivorship resources distributed free of charge to patients, clinicians, and policymakers. There is no proprietary technology platform, mobile application, or AI capability disclosed in the source data. Its intellectual assets are reputational and institutional — brand recognition as Canada's only national breast-cancer-exclusive organization, trust metrics (92% of Canadians polled would trust coalition-developed treatment guidelines), and standard-setting authority through first-of-kind consensus publications.

Breast Cancer Canada operates as a charitable nonprofit with revenue derived from corporate research partnerships (notably AstraZeneca Canada as Founding Research Partner for Survivorship at $200,000), cause-marketing campaigns (the Paint it Pink partnership with CertaPro Painters and BCRF has raised over $830,000 since 2019, with $130,000 raised in 2025 against a $165,000 goal), event sponsorships (Amoena Canada Inc., DSV Global Transport and Logistics), and individual donations. All programs and services are provided free to patients and the public; no commercial pricing applies. The organization maintains a lean operational footprint of 1-10 employees supplemented by senior executive leadership (CEO Kimberly Carson; Chief Healthcare Transformation Officer Adina Isenberg, appointed in 2026 to lead the survivorship pillar).

Short descriptiontext

Breast Cancer Canada is a national Canadian nonprofit founded in 1991 that advances breast cancer research, publishes national consensus treatment guidelines, and delivers survivorship support programs for patients, clinicians, and policymakers across Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSarnia, Canada
HQ citystring
Sarnia
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
breast cancer research, cancer survivorship support, nonprofit health advocacy, clinical research funding, patient advocacy programs
Industry2 codes
1Hospitals, Clinics & Charitable Healthcare Providers
CodeBPAGACABPrimaryYes
2Breast Oncology
CodeHLAKAFAJPrimaryNo
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Health Services8000
Product category
Nonprofit Health Advocacy and Cancer Research
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Breast Cancer Canada is a national nonprofit that funds personalized breast cancer research across Canada and delivers survivorship support programs addressing the physical, emotional, and financial needs of breast cancer patients and survivors post-treatment. Its portfolio includes the National Survivorship Strategy (fifth strategic pillar), national consensus clinical guidelines co-developed with the REAL Canadian Breast Cancer Alliance, the Annual Progress Report benchmarking breast cancer care nationwide, and community fundraising initiatives such as the Walk-a-Thon to Mother's Day. All programs are delivered free to patients, clinicians, and the public.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 87% reduction in Saskatchewan's breast cancer wait list through a cross-provincial care initiative sending patients to Calgary for treatment.
+1 more record
Product overview1 text field

Breast Cancer Canada is a non-profit charitable organization focused on breast cancer research, advocacy, and patient support. Rather than offering a unified technology product, the organization provides a portfolio of programs including its National Survivorship Strategy (addressing post-treatment care), national clinical guidelines developed with the REAL Canadian Breast Cancer Alliance, annual progress reports on the state of breast cancer care in Canada, and fundraising events such as the Walk-a-Thon to Mother's Day. These offerings work together to advance breast cancer research, improve care standards, and support survivors across Canada.

Product and service4 records
1National Survivorship Strategy
CategoryPatient support program / strategic initiative
Description

A national strategic program (the organization's fifth strategic pillar) focused on addressing critical gaps in post-treatment care for breast cancer survivors, including long-term physical, emotional, and financial challenges after treatment. Targeted at breast cancer patients, survivors, clinicians, and policymakers across Canada.

2National Consensus Recommendations for Breast Cancer Care
CategoryClinical practice guidelines
Description

First-ever national consensus recommendations for breast cancer care in Canada, developed in partnership with the REAL Canadian Breast Cancer Alliance and published in Current Oncology, covering all major subtypes and staging to establish standardized, evidence-based treatment standards nationwide. Targeted at healthcare providers, clinicians, and provincial health systems.

3Annual Progress Report: The State of Breast Cancer Care in Canada
CategoryResearch publication
Description

Annual research publication highlighting advances in breast cancer treatment, screening, and policy while identifying ongoing gaps in equitable access to care across Canada. Targeted at patients, clinicians, researchers, and policymakers.

4Lobular Breast Cancer Awareness Initiative
CategoryAwareness and research advocacy program
Description

Awareness program delivered in partnership with the Lobular Breast Cancer Alliance to raise awareness of invasive lobular carcinoma, the second most common breast cancer type representing 15% of diagnoses but receiving less than 1% of breast cancer research funding. Targeted at researchers, clinicians, and the Canadian public.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1REAL Canadian Breast Cancer Alliance
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance jointly released the first-ever national consensus recommendations for breast cancer care in Canada, published in Current Oncology. The initiative covers all major subtypes and staging to establish standardized, evidence-based treatment standards nationwide.

financialpost.com
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-12-10
Description

CertaPro Painters runs its annual Paint it Pink campaign in partnership with Breast Cancer Canada and the Breast Cancer Research Foundation. Since 2019, the campaign has raised over $830,000 supporting clinical trial enrollments and breast cancer research. Franchisees donate a percentage of painting projects during the campaign.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-15
Description

Breast Cancer Canada and the Lobular Breast Cancer Alliance opened the market at TMX Group in Toronto to mark Global Lobular Breast Cancer Awareness Day. The City of Toronto officially proclaimed the awareness day. The Lobular Breast Cancer Alliance is the only organization focused exclusively on invasive lobular carcinoma, which represents 15% of annual breast cancer diagnoses but receives less than 1% of breast cancer research funding.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Amoena Canada Inc. is a sponsor of Breast Cancer Canada's annual Walk-a-Thon to Mother's Day, supporting the organization's fundraising efforts to advance personalized breast cancer research across Canada.

Strategic tierMinorTypeGTM or Marketing Partner
Description

DSV Global Transport and Logistics is a sponsor of Breast Cancer Canada's annual Walk-a-Thon to Mother's Day, contributing to fundraising efforts for personalized breast cancer research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Breast Cancer Research Foundation co-partners with Breast Cancer Canada on the Paint it Pink campaign. BCRF is a leading global breast cancer research funder, and the partnership channels campaign funds to clinical trial enrollments for patients.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The largest US-based breast cancer nonprofit, funding research, advocacy, and patient support globally. Comparable mission and cause-marketing model, though operating at much larger scale and primarily US-focused.

TypeDirect peer
Description

Canada's largest national health nonprofit focused on cancer, including breast cancer research, advocacy, and patient support. Directly comparable as a Canada-based cancer charity competing for the same donor and corporate-partner dollars.

TypeBroad incumbent
Description

US-based breast cancer nonprofit providing education, early detection, and patient support services. Comparable in mission and patient-support focus, though primarily US-focused rather than national to Canada.

TypeDirect peer
Description

Canadian charity focused on breast cancer awareness, education, and support, particularly for younger women. Directly comparable as a Canada-based breast cancer nonprofit with overlapping donor base and advocacy mission.

TypeDirect peer
Description

Leading global breast cancer research funder and an active co-partner of Breast Cancer Canada on the Paint it Pink campaign. Comparable as a research-focused breast cancer nonprofit with similar corporate fundraising playbooks.

TypeEmerging player
Description

US-based nonprofit focused on young women diagnosed with breast cancer. Comparable as a breast cancer advocacy and patient-support organization with a narrower demographic focus than Breast Cancer Canada.

TypeRegional player
Description

UK-based breast cancer charity funding research and awareness. Comparable mission and cause-marketing approach, though operating in a different geography and unlikely to compete directly for Canadian donors.

TypeOthers
Description

Global pharmaceutical company and Breast Cancer Canada's Founding Research Partner for Survivorship. Comparable as a strategic ecosystem participant in breast cancer research funding and clinical trial enablement, though not a nonprofit peer.

TypeDirect peer
Description

The only organization exclusively focused on invasive lobular carcinoma. Already a strategic co-partner of Breast Cancer Canada via the TMX market-opening initiative, making it a directly comparable subtype-focused advocacy nonprofit.

10REAL Canadian Breast Cancer Alliance
TypeDirect peer
Description

Canadian coalition of breast cancer experts and organizations. Already a co-author with Breast Cancer Canada of the first-ever national consensus recommendations, making it a directly comparable Canadian breast cancer coalition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Breast Cancer Canada

Nonprofit Health Advocacy and Cancer Researchbreastcancerprogress.ca

Breast Cancer Canada is a national Canadian nonprofit founded in 1991 that advances breast cancer research, publishes national consensus treatment guidelines, and delivers survivorship support programs for patients, clinicians, and policymakers across Canada.

What Breast Cancer Canada does

Breast Cancer Canada is a national nonprofit organization founded in 1991 and headquartered in Sarnia, Canada, dedicated to advancing breast cancer research, survivorship support, and patient advocacy across Canada. The organization serves three primary constituencies: breast cancer patients and survivors (the primary segment, focused on post-treatment physical, emotional, and financial support), provincial healthcare systems and governments (addressing diagnostic capacity and wait-list disparities), and healthcare providers and clinicians (advancing standardized, evidence-based treatment standards). Its core programs include the National Survivorship Strategy (launched in 2026 as its fifth strategic pillar with a $200,000 AstraZeneca Canada partnership), the National Consensus Recommendations for Breast Cancer Care co-developed with the REAL Canadian Breast Cancer Alliance and published in Current Oncology, an annual Progress Report tracking the state of breast cancer care in Canada, the Walk-a-Thon to Mother's Day national fundraising event, and the Lobular Breast Cancer Awareness Initiative conducted with the Lobular Breast Cancer Alliance.

The organization's underlying 'product' surface is programmatic rather than technological: clinical guidelines, research reports, awareness campaigns, and survivorship resources distributed free of charge to patients, clinicians, and policymakers. There is no proprietary technology platform, mobile application, or AI capability disclosed in the source data. Its intellectual assets are reputational and institutional — brand recognition as Canada's only national breast-cancer-exclusive organization, trust metrics (92% of Canadians polled would trust coalition-developed treatment guidelines), and standard-setting authority through first-of-kind consensus publications.

Breast Cancer Canada operates as a charitable nonprofit with revenue derived from corporate research partnerships (notably AstraZeneca Canada as Founding Research Partner for Survivorship at $200,000), cause-marketing campaigns (the Paint it Pink partnership with CertaPro Painters and BCRF has raised over $830,000 since 2019, with $130,000 raised in 2025 against a $165,000 goal), event sponsorships (Amoena Canada Inc., DSV Global Transport and Logistics), and individual donations. All programs and services are provided free to patients and the public; no commercial pricing applies. The organization maintains a lean operational footprint of 1-10 employees supplemented by senior executive leadership (CEO Kimberly Carson; Chief Healthcare Transformation Officer Adina Isenberg, appointed in 2026 to lead the survivorship pillar).

Breast Cancer Canada firmographics

Firmographics
Name
Breast Cancer Canada
Legal name
Breast Cancer Canada
Website
https://breastcancerprogress.ca
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
1–10 employees
Short description
Breast Cancer Canada is a national Canadian nonprofit founded in 1991 that advances breast cancer research, publishes national consensus treatment guidelines, and delivers survivorship support programs for patients, clinicians, and policymakers across Canada.
Ownership category
akta.pro rank

Breast Cancer Canada industry classification

Industry
Product category
Nonprofit Health Advocacy and Cancer Research
NAICS
Voluntary Health Organizations (813212)
SIC
Services-Health Services (8000)
akta.pro primary industry
Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB)
akta.pro secondary industry
Breast Oncology (HLAKAFAJ)

Keywords

  • Breast cancer research
  • Cancer survivorship support
  • Nonprofit health advocacy
  • Clinical research funding
  • Patient advocacy programs

Where Breast Cancer Canada is headquartered

Location

Headquarters

HQ city
Sarnia
HQ country
Canada
HQ region
North America

Markets served

Breast Cancer Canada business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels6 records

Breast Cancer Canada product offering

Product offering

Core offering

Breast Cancer Canada is a national nonprofit that funds personalized breast cancer research across Canada and delivers survivorship support programs addressing the physical, emotional, and financial needs of breast cancer patients and survivors post-treatment. Its portfolio includes the National Survivorship Strategy (fifth strategic pillar), national consensus clinical guidelines co-developed with the REAL Canadian Breast Cancer Alliance, the Annual Progress Report benchmarking breast cancer care nationwide, and community fundraising initiatives such as the Walk-a-Thon to Mother's Day. All programs are delivered free to patients, clinicians, and the public.

Product overview

Breast Cancer Canada is a non-profit charitable organization focused on breast cancer research, advocacy, and patient support. Rather than offering a unified technology product, the organization provides a portfolio of programs including its National Survivorship Strategy (addressing post-treatment care), national clinical guidelines developed with the REAL Canadian Breast Cancer Alliance, annual progress reports on the state of breast cancer care in Canada, and fundraising events such as the Walk-a-Thon to Mother's Day. These offerings work together to advance breast cancer research, improve care standards, and support survivors across Canada.

Differentiator

Problem solved

Functional benefit

Products and services

  • National Survivorship Strategy A national strategic program (the organization's fifth strategic pillar) focused on addressing critical gaps in post-treatment care for breast cancer survivors, including long-term physical, emotional, and financial challenges after treatment. Targeted at breast cancer patients, survivors, clinicians, and policymakers across Canada.
  • National Consensus Recommendations for Breast Cancer Care First-ever national consensus recommendations for breast cancer care in Canada, developed in partnership with the REAL Canadian Breast Cancer Alliance and published in Current Oncology, covering all major subtypes and staging to establish standardized, evidence-based treatment standards nationwide. Targeted at healthcare providers, clinicians, and provincial health systems.
  • Annual Progress Report: The State of Breast Cancer Care in Canada Annual research publication highlighting advances in breast cancer treatment, screening, and policy while identifying ongoing gaps in equitable access to care across Canada. Targeted at patients, clinicians, researchers, and policymakers.
  • Lobular Breast Cancer Awareness Initiative Awareness program delivered in partnership with the Lobular Breast Cancer Alliance to raise awareness of invasive lobular carcinoma, the second most common breast cancer type representing 15% of diagnoses but receiving less than 1% of breast cancer research funding. Targeted at researchers, clinicians, and the Canadian public.

Quantifiable outcome

  • 87% reduction in Saskatchewan's breast cancer wait list through a cross-provincial care initiative sending patients to Calgary for treatment.
  • +1 more outcomes

Companies that use Breast Cancer Canada

Customer profile

Segments3 records

Ideal customer profiles4 records

Breast Cancer Canada technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Breast Cancer Canada partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • REAL Canadian Breast Cancer AlliancecoreStrategic or Co-development Partner · 30 April 2026Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance jointly released the first-ever national consensus recommendations for breast cancer care in Canada, published in Current Oncology. The initiative covers all major subtypes and staging to establish standardized, evidence-based treatment standards nationwide.
  • CertaPro PainterscoreGTM or Marketing Partner · 10 December 2025CertaPro Painters runs its annual Paint it Pink campaign in partnership with Breast Cancer Canada and the Breast Cancer Research Foundation. Since 2019, the campaign has raised over $830,000 supporting clinical trial enrollments and breast cancer research. Franchisees donate a percentage of painting projects during the campaign.
  • Lobular Breast Cancer AlliancecoreStrategic or Co-development Partner · 15 October 2025Breast Cancer Canada and the Lobular Breast Cancer Alliance opened the market at TMX Group in Toronto to mark Global Lobular Breast Cancer Awareness Day. The City of Toronto officially proclaimed the awareness day. The Lobular Breast Cancer Alliance is the only organization focused exclusively on invasive lobular carcinoma, which represents 15% of annual breast cancer diagnoses but receives less than 1% of breast cancer research funding.
  • Amoena Canada Inc.minorGTM or Marketing PartnerAmoena Canada Inc. is a sponsor of Breast Cancer Canada's annual Walk-a-Thon to Mother's Day, supporting the organization's fundraising efforts to advance personalized breast cancer research across Canada.
  • DSV Global Transport and LogisticsminorGTM or Marketing PartnerDSV Global Transport and Logistics is a sponsor of Breast Cancer Canada's annual Walk-a-Thon to Mother's Day, contributing to fundraising efforts for personalized breast cancer research.
  • Breast Cancer Research Foundation (BCRF)coreStrategic or Co-development PartnerThe Breast Cancer Research Foundation co-partners with Breast Cancer Canada on the Paint it Pink campaign. BCRF is a leading global breast cancer research funder, and the partnership channels campaign funds to clinical trial enrollments for patients.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Breast Cancer Canada competitors and assessment

Company assessment

Broad incumbents

  • Susan G. Komen: The largest US-based breast cancer nonprofit, funding research, advocacy, and patient support globally. Comparable mission and cause-marketing model, though operating at much larger scale and primarily US-focused.
  • National Breast Cancer Foundation (US): US-based breast cancer nonprofit providing education, early detection, and patient support services. Comparable in mission and patient-support focus, though primarily US-focused rather than national to Canada.

Direct peers

  • Canadian Cancer Society: Canada's largest national health nonprofit focused on cancer, including breast cancer research, advocacy, and patient support. Directly comparable as a Canada-based cancer charity competing for the same donor and corporate-partner dollars.
  • Rethink Breast Cancer: Canadian charity focused on breast cancer awareness, education, and support, particularly for younger women. Directly comparable as a Canada-based breast cancer nonprofit with overlapping donor base and advocacy mission.
  • Breast Cancer Research Foundation (BCRF): Leading global breast cancer research funder and an active co-partner of Breast Cancer Canada on the Paint it Pink campaign. Comparable as a research-focused breast cancer nonprofit with similar corporate fundraising playbooks.
  • Lobular Breast Cancer Alliance: The only organization exclusively focused on invasive lobular carcinoma. Already a strategic co-partner of Breast Cancer Canada via the TMX market-opening initiative, making it a directly comparable subtype-focused advocacy nonprofit.
  • REAL Canadian Breast Cancer Alliance: Canadian coalition of breast cancer experts and organizations. Already a co-author with Breast Cancer Canada of the first-ever national consensus recommendations, making it a directly comparable Canadian breast cancer coalition.

Emerging players

  • Young Survival Coalition: US-based nonprofit focused on young women diagnosed with breast cancer. Comparable as a breast cancer advocacy and patient-support organization with a narrower demographic focus than Breast Cancer Canada.

Regional players

  • Pink Ribbon Foundation: UK-based breast cancer charity funding research and awareness. Comparable mission and cause-marketing approach, though operating in a different geography and unlikely to compete directly for Canadian donors.

Others

  • AstraZeneca (oncology business): Global pharmaceutical company and Breast Cancer Canada's Founding Research Partner for Survivorship. Comparable as a strategic ecosystem participant in breast cancer research funding and clinical trial enablement, though not a nonprofit peer.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Breast Cancer Canada social profiles

Digital presence

Breast Cancer Canada financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Breast Cancer Canada leadership team

Management profile

Number of profiles

Profiles2 records

Breast Cancer Canada funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Breast Cancer Canada M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breast Cancer Canada

What does Breast Cancer Canada do?

Breast Cancer Canada is a national nonprofit that funds personalized breast cancer research across Canada and delivers survivorship support programs addressing the physical, emotional, and financial needs of breast cancer patients and survivors post-treatment. Its portfolio includes the National Survivorship Strategy (fifth strategic pillar), national consensus clinical guidelines co-developed with the REAL Canadian Breast Cancer Alliance, the Annual Progress Report benchmarking breast cancer care nationwide, and community fundraising initiatives such as the Walk-a-Thon to Mother's Day. All programs are delivered free to patients, clinicians, and the public.

Is Breast Cancer Canada a public or private company?

Breast Cancer Canada is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Breast Cancer Canada founded?

Breast Cancer Canada was founded in 1991. It employs 1 to 10 people.

Where is Breast Cancer Canada based?

Breast Cancer Canada is headquartered in Sarnia, Canada, in the North America region.

Who are Breast Cancer Canada's main competitors?

Broad incumbents on record are Susan G. Komen and National Breast Cancer Foundation (US). Direct peers are Canadian Cancer Society, Rethink Breast Cancer, Breast Cancer Research Foundation (BCRF), Lobular Breast Cancer Alliance and REAL Canadian Breast Cancer Alliance. Young Survival Coalition is listed as an emerging player. Pink Ribbon Foundation is listed as a regional player. AstraZeneca (oncology business) is listed as an others.

Does Breast Cancer Canada have an API?

No public API is recorded for Breast Cancer Canada.

What industry is Breast Cancer Canada in?

Breast Cancer Canada's product category is Nonprofit Health Advocacy and Cancer Research. Its primary akta.pro industry code is BPAGACAB, Hospitals, Clinics & Charitable Healthcare Providers, with a secondary code of HLAKAFAJ, Breast Oncology. Its NAICS code is 813212 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceRoche Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for Perjeta® (pertuzumab) for the neoadjuvant treatment of aggressive early stage breast cancerRoche Canada completed negotiations with the pan-Canadian Pharmaceutical Alliance for Perjeta (pertuzumab) in combination with trastuzumab and chemotherapy for neoadjuvant treatment of HER2-positive early breast cancer. The pCPA's August 10, 2026 deadline follows a positive CDA-AMC recommendation, bringing the drug closer to public access.Financial PostWhat Happens After the "All Clear"? Breast Cancer Canada Calls for Urgent Action to Support Canadian Breast Cancer SurvivorsBreast Cancer Canada has launched a national survivorship strategy, its fifth strategic pillar, calling for urgent government investment to address critical gaps in post-treatment care for breast cancer survivors. The organization announced a $200,000 partnership with AstraZeneca Canada as its Founding Research Partner for Survivorship, along with the appointment of Adina Isenberg as Chief Healthcare Transformation Officer. With breast cancer survival rates continuing to improve and younger Canadians increasingly being diagnosed, BCC is emphasizing the need to evolve the conversation around breast cancer to focus on quality of life beyond diagnosis.BreastcancerBCC’s Survivorship StrategyBreast Cancer Canada launched a national survivorship strategy, its fifth strategic pillar, to address post-treatment care gaps. It announced a $200,000 matched grant with AstraZeneca Canada and appointed Adina Isenberg as Chief Healthcare Transformation Officer. The initiative aims to improve long-term quality of life for younger survivors.Global NewsThese are the Canadian regions with the highest rates of breast cancer - NationalA Statistics Canada study examining breast cancer rates between 2010 and 2020 found that rural regions in Quebec, Ontario, and the Prairies, as well as urban centers with large immigrant and racialized populations, experienced the highest breast cancer risks, while rates were lowest in Montreal, Toronto, Vancouver, and remote northern regions. Experts cite lack of mammogram access and resources in underserved areas as key contributors to regional disparities. Most Canadian provinces and territories have lowered mammogram eligibility to age 40, with Quebec remaining the sole exception.Financial PostBreast Cancer Canada's annual Walk-a-Thon to Mother's Day returns to advance breast cancer research.Breast Cancer Canada is hosting its annual Walk-a-Thon to Mother’s Day on May 10, 2026, at Streetsville Memorial Park in Mississauga, Ontario, to raise funds for personalized breast cancer research across Canada. The national event, which also offers a virtual participation option for Canadians nationwide, features sponsors including Amoena Canada Inc. and DSV Global Transport and Logistics. With more than 30,000 Canadians diagnosed with breast cancer annually, the walk aims to advance earlier detection, improved treatment options, and more equitable access to care.Financial PostBreast Cancer Canada and REAL Canadian Breast Cancer Alliance Establish National Recommendations for Breast CancerBreast Cancer Canada and the REAL Canadian Breast Cancer Alliance have released the first-ever national consensus recommendations for breast cancer care in Canada, published in Current Oncology, covering all major subtypes and staging to establish standardized, evidence-based treatment standards nationwide. The initiative aims to address significant disparities in patient outcomes that currently vary depending on geographic location within Canada. A recent national poll conducted by Breast Cancer Canada found that 92% of Canadians would trust national treatment guidelines developed by a coalition of Canada's top breast cancer experts.NewswireCertaPro Painters® Raises $130,000 for Breast Cancer Research as Part of its Seventh Annual Paint it Pink CampaignCertaPro Painters® raised $130,000 for breast cancer research as part of its seventh annual Paint it Pink campaign, partnering with the Breast Cancer Research Foundation and Breast Cancer Canada. The campaign, supported by 139 franchisees who donated a percentage of painting projects completed between October 1 and November 30, has now raised over $830,000 total since 2019. The company stated the initiative was inspired by personal loss and reflects its commitment to community support among employees and franchisees.PR NewswireCertaPro Painters® Raises $130,000 for Breast Cancer Research as Part of its Seventh Annual Paint it Pink CampaignCertaPro Painters raised $130,000 for breast cancer research as part of its seventh annual Paint it Pink campaign, partnering with the Breast Cancer Research Foundation and Breast Cancer Canada. The 2025 campaign involved 139 franchisees donating a percentage of painting projects completed between October 1 and November 30. Since 2019, the Paint it Pink initiative has raised over $830,000 in total, funding over 330 patient enrollments in clinical trials.Business Wire BlogBreast Cancer Canada Releases 2025 Annual Progress Report: The State of Breast Cancer Care in CanadaBreast Cancer Canada released its 2025 Annual Progress Report on the state of breast cancer care in Canada, highlighting that seven new breast cancer therapies were approved by Health Canada and the Canada Drug Agency in the past year, though average time from approval to public access remains over 12 months. The report also notes that Ontario's new FAST track program expedites funding for approved cancer therapies within six months, and advocacy efforts led to recommendations for public funding access of pertuzumab and abemaciclib in provinces outside Quebec. Key findings include that 55% of Canadians have access to clinical trials and 72% of patients feel unprepared to manage recurrence risk, underscoring ongoing gaps in equitable care access.NewsfileGlobal Lobular Breast Cancer Awareness Day Opens the MarketBreast Cancer Canada and the Lobular Breast Cancer Alliance joined representatives to open the market at TMX Group in Toronto on October 15, 2025, in recognition of Lobular Breast Cancer Awareness Day, which the City of Toronto officially proclaimed. The awareness day highlights invasive lobular carcinoma, which represents 15% of annual breast cancer diagnoses as the second most common type but receives less than 1% of breast cancer research funding and has no specific treatments. The Lobular Breast Cancer Alliance serves as the only organization focused exclusively on raising awareness and providing information about ILC.